Navigation Links
K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court
Date:8/8/2012

our forward-looking statements.

Because the factors referred to above, as well as the statements included in Part I, Item 1A—"Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended March 31, 2012 and under the heading "Risk Factors" in our Registration Statement on Form S-1 filed with the Securities and Exchange Commission on July 31, 2012, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. All forward-looking statements attributable to us are expressly qualified in their entirety by the cautionary statements in this "Cautionary Note Regarding Forward-Looking Statements" and the risk factors that are included under Part I, Item 1A of the our Annual Report on Form 10-K for the fiscal year ended March 31, 2012 and under the heading "Risk Factors" in our Registration Statement on Form S-1 filed with the Securities and Exchange Commission on July 31, 2012. Further, any forward-looking statement speaks only as of the date on which it is made and we are under no obligation to update any of the forward-looking statements after the date of this release. New factors emerge from time to time, and it is not possible for us to predict which factors will arise, when they will arise and/or their effects. In addition, we cannot assess the impact of each factor on our future business or financial condition or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.


'/>"/>
SOURCE K-V Pharmaceutical Company
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. The respective roles of the public and private sectors in pharmaceutical innovation
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... Dental decay is the number one chronic disease ... Crisafulli of Crisafulli Dental those statistics are no longer daunting. ... and implemented a cavity prevention program developed by CariFree that ... to 74% . The system is known as ... a solution to dental decay that works,” says Dr. Crisafulli, ...
(Date:6/19/2013)... , June 20, 2013 ... productivity with technology solutions for pharmaceutical and chemical ... Glaxo Wellcome Manufacturing Pte. Ltd. and Siemens Pte. ... a new A*STAR R&D Consortium Programme - Innovative ... A*STAR,s Institute of Chemical and Engineering Sciences (ICES), ...
(Date:6/19/2013)... 19, 2013 An article posted earlier this ... increasing number of uses for probiotics. The article stated that ... the associate benefits may beeb listed, the actual use ... helping clear skin conditions. While the total uses of probiotics ... the the uses of these “miracle” bacterium, and debunked the ...
(Date:6/19/2013)... Clinverse, Inc. , a ... trials, today announced it will be exhibiting and ... in Boston, June 24-26, 2013. Clinverse’s eClinical ... fully configurable, cloud-based clinical financial lifecycle system. , ... Clinverse’s eClinical Commerce Network, automates site contract set-up ...
Breaking Biology Technology:Crisafulli Dental Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74% 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2
... Stem cell-enriched autologous fat enables sustainable breast augmentation ... the media: For years a French company has been ... cause cancer. More than 100,000 women worldwide must now ... or carrying a "time bomb" in their bodies. Stem ...
... Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it will ... the Windsor Room of the Sir Francis Drake Hotel as ... emerging biotech companies held over 3 days this week in ... attendees are expected to be listening to presentations by up ...
... SEATTLE, Jan. 10, 2012  Omeros Corporation (NASDAQ: OMER ... selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, ... unlocked by Omeros to 23, representing 30 percent of the ... unlocked by Omeros for drug development equals half of the ...
Cached Biology Technology:Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 2Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 4Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 5
(Date:6/19/2013)... the journal Polar Biology, researchers report using DNA from tissues ... new type of killer whale ( Orcinus orca ). ... stranded on a New Zealand beach and a skeleton was ... but it was almost 50 years before this unique form ... and bulbous forehead, was documented alive in the wild. ...
(Date:6/19/2013)... Minn. , June 19, 2013 ... specializing in clinical study management systems, is pleased to ... to be held June 23-27 in Boston ... that MedNet, a recognized leader in cloud-based eClinical solutions, ... MedNet will be showcasing iMedNet™ EDC ...
(Date:6/19/2013)... A new variety of canary seeds bred specifically for ... be ideal for people with celiac disease (CD), scientists ... Journal of Agricultural and Food Chemistry . , ... least 3 million people in the United States alone ... eating wheat, barley, rye and other grains that contain ...
Breaking Biology News(10 mins):MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2
... Calling the results "extremely surprising," researchers from the ... report that methane gas concentrations in the Gulf of ... after a massive release occurred following the Deepwater Horizon ... led by oceanographers John Kessler of Texas A&M and ...
... exploring the genetic culprits behind a host of neuromuscular ... a team working at the National Institute of Standards ... single cells to extract and examine their mitochondria. ... "engines"the mitochondria that are in large part responsible for ...
... Jan. 6, 2011 News media now can apply for ... National Meeting & Exposition March 27-31, 2011, in Anaheim, Calif., ... Held during the International Year of Chemistry (IYC), ... Center and at area hotels. With nearly 9,500 presentations ...
Cached Biology News:UCSB, Texas A&M scientists find methane gas concentrations have returned to near-normal levels 2Extracting cellular 'engines' may aid in understanding mitochondrial diseases 2
... Band Purification Kit, 100. For the purification, isolation ... (0.1-10 kb) from solution and from TAE or ... solution in as little as 5 min or ... glass fiber matrix columns provide consistent results and ...
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Newborn Bovine Serum Heat-Inactivated...
Mycoplasma and virus tested...
Biology Products: